Menopausal hormone therapy and risk of biliary tract cancers.

Sarah S Jackson Ruth M PfeifferChiara GabbiLesley AndersonShahinaz M GadallaJill Koshiol

Published in: Hepatology (Baltimore, Md.) (2021)

Combination MHT formulations and oral administrations are associated with increased GBC risk, while estrogen-only formulations were associated with a lower cholangiocarcinoma risk. MHT formulation and administration should be carefully considered when prescribing.

Keyphrases

primary care
drug delivery
stem cells
bone marrow
smoking cessation
drug induced
childhood cancer